Intrauterine administration of autologous peripheral blood mononuclear cells (<scp>PBMC</scp>s) activated by <scp>HCG</scp> improves the implantation and pregnancy rates in patients with repeated implantation failure: a prospective randomized study

Abstract

These findings indicate that intrauterine administration of autologous PBMC activated by HCG in vitro effectively improves embryo implantation in patients with three or more IVF failures.